272 related articles for article (PubMed ID: 34493413)
1. Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial.
Thurtle D; Jenkins V; Freeman A; Pearson M; Recchia G; Tamer P; Leonard K; Pharoah P; Aning J; Madaan S; Goh C; Hilman S; McCracken S; Ilie PC; Lazarowicz H; Gnanapragasam V
Eur Urol; 2021 Nov; 80(5):661-669. PubMed ID: 34493413
[TBL] [Abstract][Full Text] [Related]
2. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial on the effect of an online decision aid for young female cancer patients regarding fertility preservation.
Ehrbar V; Urech C; Rochlitz C; Zanetti Dällenbach R; Moffat R; Stiller R; Germeyer A; Nawroth F; Dangel A; Findeklee S; Tschudin S
Hum Reprod; 2019 Sep; 34(9):1726-1734. PubMed ID: 31398258
[TBL] [Abstract][Full Text] [Related]
4. Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial.
Evans R; Joseph-Williams N; Edwards A; Newcombe RG; Wright P; Kinnersley P; Griffiths J; Jones M; Williams J; Grol R; Elwyn G
J Med Internet Res; 2010 Aug; 12(3):e27. PubMed ID: 20693148
[TBL] [Abstract][Full Text] [Related]
5. Navigate: a study protocol for a randomised controlled trial of an online treatment decision aid for men with low-risk prostate cancer and their partners.
Schofield P; Gough K; Hyatt A; White A; Frydenberg M; Chambers S; Gordon LG; Gardiner R; Murphy DG; Cavedon L; Richards N; Murphy B; Quinn S; Juraskova I
Trials; 2021 Jan; 22(1):49. PubMed ID: 33430950
[TBL] [Abstract][Full Text] [Related]
6. Screening for prostate cancer.
Ilic D; Neuberger MM; Djulbegovic M; Dahm P
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
[TBL] [Abstract][Full Text] [Related]
7. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
[TBL] [Abstract][Full Text] [Related]
8. Decisional conflict in economically disadvantaged men with newly diagnosed prostate cancer: baseline results from a shared decision-making trial.
Kaplan AL; Crespi CM; Saucedo JD; Connor SE; Litwin MS; Saigal CS
Cancer; 2014 Sep; 120(17):2721-7. PubMed ID: 24816472
[TBL] [Abstract][Full Text] [Related]
9. Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model.
Thurtle DR; Greenberg DC; Lee LS; Huang HH; Pharoah PD; Gnanapragasam VJ
PLoS Med; 2019 Mar; 16(3):e1002758. PubMed ID: 30860997
[TBL] [Abstract][Full Text] [Related]
10. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.
Guillaumier S; Peters M; Arya M; Afzal N; Charman S; Dudderidge T; Hosking-Jervis F; Hindley RG; Lewi H; McCartan N; Moore CM; Nigam R; Ogden C; Persad R; Shah K; van der Meulen J; Virdi J; Winkler M; Emberton M; Ahmed HU
Eur Urol; 2018 Oct; 74(4):422-429. PubMed ID: 29960750
[TBL] [Abstract][Full Text] [Related]
11. The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial.
Berry DL; Halpenny B; Hong F; Wolpin S; Lober WB; Russell KJ; Ellis WJ; Govindarajulu U; Bosco J; Davison BJ; Bennett G; Terris MK; Barsevick A; Lin DW; Yang CC; Swanson G
Urol Oncol; 2013 Oct; 31(7):1012-21. PubMed ID: 22153756
[TBL] [Abstract][Full Text] [Related]
12. Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness.
Woods BS; Sideris E; Sydes MR; Gannon MR; Parmar MKB; Alzouebi M; Attard G; Birtle AJ; Brock S; Cathomas R; Chakraborti PR; Cook A; Cross WR; Dearnaley DP; Gale J; Gibbs S; Graham JD; Hughes R; Jones RJ; Laing R; Mason MD; Matheson D; McLaren DB; Millman R; O'Sullivan JM; Parikh O; Parker CC; Peedell C; Protheroe A; Ritchie AWS; Robinson A; Russell JM; Simms MS; Srihari NN; Srinivasan R; Staffurth JN; Sundar S; Thalmann GN; Tolan S; Tran ATH; Tsang D; Wagstaff J; James ND; Sculpher MJ
Eur Urol Oncol; 2018 Dec; 1(6):449-458. PubMed ID: 31158087
[TBL] [Abstract][Full Text] [Related]
13. Comparison of explicit values clarification method (VCM), implicit VCM and no VCM decision aids for men considering prostate cancer screening: protocol of a randomized trial.
Baptista S; Heleno B; Teixeira A; Taylor KL; Martins C
BMC Med Inform Decis Mak; 2020 Apr; 20(1):78. PubMed ID: 32349746
[TBL] [Abstract][Full Text] [Related]
14. The impact of adding cost information to a conversation aid to support shared decision making about low-risk prostate cancer treatment: Results of a stepped-wedge cluster randomised trial.
Politi MC; Forcino RC; Parrish K; Durand MA; O'Malley AJ; Moses R; Cooksey K; Elwyn G
Health Expect; 2023 Oct; 26(5):2023-2039. PubMed ID: 37394739
[TBL] [Abstract][Full Text] [Related]
15. Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.
Berry DL; Hong F; Blonquist TM; Halpenny B; Xiong N; Filson CP; Master VA; Sanda MG; Chang P; Chien GW; Jones RA; Krupski TL; Wolpin S; Wilson L; Hayes JH; Trinh QD; Sokoloff M
Urol Oncol; 2021 Aug; 39(8):493.e9-493.e15. PubMed ID: 33353864
[TBL] [Abstract][Full Text] [Related]
16. Impact of a web-based prostate cancer treatment decision aid on patient-reported decision process parameters: results from the Prostate Cancer Patient Centered Care trial.
Cuypers M; Lamers RED; Kil PJM; van de Poll-Franse LV; de Vries M
Support Care Cancer; 2018 Nov; 26(11):3739-3748. PubMed ID: 29752528
[TBL] [Abstract][Full Text] [Related]
17. Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium.
Diefenbach MA; Marziliano A; Tagai EK; Pfister H; Lapitan E; Hall SJ; Vira M; Ibrahim S; Aibel K; Kutikov A; Horwitz EM; Miyamoto C; Reese AC; Miller SM
J Med Internet Res; 2023 Oct; 25():e46552. PubMed ID: 37862103
[TBL] [Abstract][Full Text] [Related]
18. Examining the impact of a multimedia intervention on treatment decision-making among newly diagnosed prostate cancer patients: results from a nationwide RCT.
Diefenbach MA; Benedict C; Miller SM; Stanton AL; Ropka ME; Wen KY; Fleisher LG; Mohamed NE; Hall SJ
Transl Behav Med; 2018 Nov; 8(6):876-886. PubMed ID: 29982747
[TBL] [Abstract][Full Text] [Related]
19. Low conflict and high satisfaction: Decisional outcomes after attending a combined clinic to choose between robotic prostatectomy and radiotherapy for prostate cancer.
Smith A'; Rincones O; Mancuso P; Sidhom M; Wong K; Berry M; Forstner D; Ngo D; Bokey L; Girgis A
Urol Oncol; 2022 Jan; 40(1):8.e1-8.e9. PubMed ID: 34116935
[TBL] [Abstract][Full Text] [Related]
20. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
Bratt O; Folkvaljon Y; Hjälm Eriksson M; Akre O; Carlsson S; Drevin L; Franck Lissbrant I; Makarov D; Loeb S; Stattin P
Eur Urol; 2015 Jul; 68(1):53-8. PubMed ID: 25813688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
